Neuropore Therapies Major Partnerships

Logo: UCSD

Neuropore Therapies Inc. was founded by Dr. Eliezer Masliah and colleagues from the UCSD School of Medicine. Neuropore continues to maintain active collaborations with its academic founders, gaining new insights into the mechanisms of neurodegenerative disorders and how they can be treated.

Logo: Michael J. Fox Partners

The Michael J. Fox Foundation supported the early preclinical development of NPT200-11 as a grant recipient of the Synuclein Therapeutic Acceleration Program in 2010 and 2013 and for the 1H 2014 Partnering Program for the preclinical evaluations of NPT200-11. We thank the Foundation for this vital support that enabled the advancement of NPT200-11.

Logo: UCB Partners

Neuropore Therapies, Inc. and UCB entered into a collaborative partnership in 2015 for the clinical development of NPT200-11 as a disease modifying treatment option for people living with Parkinson's disease. UCB is a global biopharma focused on severe diseases with operations in approximately 40 countries.